The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,005
Ordovás, J. M., & Corella, D. (2004) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.5.061903.180008 · Cited by 229
Stengård, J., Zerba, K. E., Pekkanen, J., Ehnholm, C., Nissinen, A. M., & Sing, C. F. (1995) · Circulation · doi:10.1161/01.cir.91.2.265 · Cited by 224
Self-citationApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215
Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study
Zhao, X., Liu, Y., Wang, X., Liu, B., Xi, Q., Guo, Q., Jiang, H., Jiang, T., & Wang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033540 · Cited by 215
Luc, G., Bard, J., Arveiler, D., Evans, A., Cambou, J., Bingham, A., Amouyel, P., Schaffer, P., Ruidavets, J., & Cambien, F. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.9.1412 · Cited by 215
An evolutionary framework for common diseases: the ancestral-susceptibility model
Rienzo, A. D., & Hudson, R. R. (2005) · Trends in Genetics · doi:10.1016/j.tig.2005.08.007 · Cited by 216
Meat‐Adaptive Genes and the Evolution of Slower Aging in Humans
Finch, C. E., & Stanford, C. B. (2004) · The Quarterly Review of Biology · doi:10.1086/381662 · Cited by 216
Shanmugan, S., & Epperson, C. N. (2014) · Human Brain Mapping · doi:10.1002/hbm.22218 · Cited by 173
Apolipoprotein E and atherosclerosis: insight from animal and human studies
Davignon, J., Cohn, J. S., Mabile, L., & Bernier, L. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00097-2 · Cited by 210
Self-citationTiret, L., de Knijff, P., Menzel, H., Ehnholm, C., Nicaud, V., & Havekes, L. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1617 · Cited by 208
Kuusisto, J., Koivisto, K. J., Kervinen, K., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Pyörälä, K., Kesäniemi, Y. A., Riekkinen, P. J., et al. (1994) · BMJ · doi:10.1136/bmj.309.6955.636 · Cited by 207
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.
Lehtimäki, T. J., Moilanen, T. P. S., Viikari, J. S. A., Akerblom, H., Ehnholm, C., Rönnemaa, T., Marniemi, J., Dahlén, G., & Nikkari, T. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43170-0 · Cited by 205
Relationship between case-control studies and the transmission/disequilibrium test
Mitchell, L. E. (2000) · Genetic Epidemiology · doi:10.1002/1098-2272(200010)19:3 · Cited by 19
The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆
Finch, C. E., & Sapolsky, R. M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00053-6 · Cited by 208
Early and late onset depression in old age: different aetiologies, same phenomenology
Brodaty, H., Luscombe, G. M., Parker, G. B., Wilhelm, K. A., Hickie, I. B., Austin, M., & Mitchell, P. B. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00317-7 · Cited by 202
Schaefer, E. J., Lamon‐Fava, S., Johnson, S., Ordovás, J. M., Schaefer, M. M., Castelli, W. P., & Wilson, P. W. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1105 · Cited by 198
Genetic variation and the lipid response to dietary intervention: a systematic review
Masson, L. F., McNeill, G., & Avenell, A. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1098 · Cited by 196
The Blood‐Brain Barrier and Cerebrovascular Pathology in Alzheimer's Disease
Kalaria, R. N. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07821.x · Cited by 196
Sasso, G. L., Schlage, W. K., Boué, S., Veljkovic, E., Peitsch, M. C., & Hoeng, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0901-1 · Cited by 206
Association of Bone Mineral Density with Apolipoprotein E Phenotype
Shiraki, M., Shiraki, Y., Aoki, C., Hosoi, T., Inoue, S., Kaneki, M., & Ouchi, Y. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1438 · Cited by 194
Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E
Raffaı̈, R. L., Dong, L., Farese, R. V., & Weisgraber, K. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201279298 · Cited by 201
The Apolipoprotein E ϵ4 Allele and Decline in Different Cognitive Systems During a 6-Year Period
Wilson, R. S., Schneider, J. A., Barnes, L. L., Beckett, L. A., Aggarwal, N. T., Cochran, E. J., Berry‐Kravis, E., Bach, J., Fox, J. H., Evans, D. A., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.7.1154 · Cited by 192
Murkin, J. M., Martzke, J. S., Buchan, A. M., Bentley, C., & Wong, C. J. (1995) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70229-6 · Cited by 191
Apolipoprotein ∈4 homozygosity in young men with coronary heart disease
BOCKXMEER, F. M. V., & Mamotte, C. D. S. (1992) · The Lancet · doi:10.1016/0140-6736(92)93288-x · Cited by 191
Updates on mouse models of Alzheimer’s disease
Zhong, M. Z., Peng, T., Duarte, M. L., Wang, M., & Cai, D. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00712-0 · Cited by 189
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
Beffert, U. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00008-3 · Cited by 190
On phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
Lipid metabolism in cognitive decline and dementia
Panza, F., D’Introno, A., Colacicco, A. M., Capurso, C. A., Pichichero, G., Capurso, S. A., Capurso, A., & Solfrizzi, V. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.007 · Cited by 188
Tang, M. X., Maestre, G. E., Tsai, W., Liu, X., Feng, L., Chung, W.-Y., Chun, M. R., Schofield, P. R., Stern, Y., Tycko, B., et al. (1996) · PubMed Central · doi:10.7916/d80v9r96 · Cited by 184
Grainger, D. J., Reckless, J., & McKilligin, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6366 · Cited by 183
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
Lane, R. M., & Farlow, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400486-jlr200 · Cited by 186
Apolipoprotein E-ε4 protects against severe liver disease caused by hepatitis C virus
Wozniak, M. A., Itzhaki, R. F., Faragher, B. E., James, M. W., Ryder, S. D., & Irving, W. L. (2002) · Hepatology · doi:10.1053/jhep.2002.34745 · Cited by 181
APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
O'Donoghue, M. C., Murphy, S. E., Zamboni, G., Nobre, A. C., & Mackay, C. E. (2018) · Cortex · doi:10.1016/j.cortex.2018.03.025 · Cited by 191
Status of Risk Factors for Vascular Dementia
Skoog, I. G. (1998) · Neuroepidemiology · doi:10.1159/000026147 · Cited by 177
Lembo, G., LUCA, N. D., Battagli, C., Iovino, G., Aretini, A., Musicco, M., Frati, G., Pompeo, F., Vecchione, C., & Trimarco, B. (2001) · Stroke · doi:10.1161/01.str.32.3.735 · Cited by 176
Genome-Wide Scan Informed by Age-Related Disease Identifies Loci for Exceptional Human Longevity
Fortney, K., Dobriban, E., Garagnani, P., Pirazzini, C., Monti, D., Mari, D., Atzmon, G., Barzilai, N., Franceschi, C., Owen, A. B., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005728 · Cited by 180
Saeed, A., Feofanova, E. V., Yu, B., Sun, W., Virani, S. S., Nambi, V., Coresh, J., Guild, C., Boerwinkle, E., Ballantyne, C. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.050 · Cited by 176
Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
Pedro‐Botet, J., Schaefer, E. J., Bakker-Arkema, R. G., Black, D. M., Stein, E., Corella, D., & Ordovás, J. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00410-5 · Cited by 173
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330020 · Cited by 171
Ilveskoski, E., Perola, M., Lehtimäki, T. J., Laippala, P. J., Savolainen, V. T., Pajarinen, J., Penttilä, A., Lalu, K. H., Männikkö, A., Liesto, K. K., et al. (1999) · Circulation · doi:10.1161/01.cir.100.6.608 · Cited by 172
Miettinen, T. A., Gylling, H., Vanhanen, H. T., & Ollus, A. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1044 · Cited by 171
Role of apolipoprotein E in neurodegenerative diseases
Giau, V. V., Bagyinszky, E., An, S. S. A., & Kim, S. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84266 · Cited by 177
Horsburgh, K. J., McCarron, M. O., White, F., & Nicoll, J. A. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00097-x · Cited by 169
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
Romas, S. N., Tang, M.-X., Berglund, L., & Mayeux, R. P. (1999) · Neurology · doi:10.1212/wnl.53.3.517 · Cited by 176
Ordovás, J. M., López‐Miranda, J., Pérez‐Jiménez, F., Rodríguez, C., Park, J.-S., Cole, T. G., & Schaefer, E. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05439-p · Cited by 168
Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation
Bonacina, F., Coe, D., Wang, G., Longhi, M. P., Baragetti, A., Moregola, A., Garlaschelli, K., Uboldi, P., Pellegatta, F., Grigore, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05322-1 · Cited by 172
Alzheimer's disease is a vasocognopathy: a new term to describe its nature
de la Torre, J. C. (2004) · Neurological Research · doi:10.1179/016164104225016254 · Cited by 168
Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet.
Tikkanen, M. J., Huttunen, J. K., Ehnholm, C., & Pietinen, P. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.285 · Cited by 168
Apolipoprotein e4 allele and cognitive decline in elderly men
Feskens, E. J. M., Havekes, L. M., Kalmijn, S., de Knijff, P., Launer, L. J., & Kromhout, D. (1994) · BMJ · doi:10.1136/bmj.309.6963.1202 · Cited by 165
Apolipoprotein E and Alzheimer's disease
Troutwine, B., Hamid, L., Lysaker, C. R., Strope, T. A., & Wilkins, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.002 · Cited by 179
Raz, N., Yang, Y., Dahle, C. L., & Land, S. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.007 · Cited by 169
Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.
Couderc, R., Mahieux, F., Bailleul, S., Fénelon, G., Mary, R. R., & Fermanian, J. (1993) · Stroke · doi:10.1161/01.str.24.5.661 · Cited by 160
Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1996) · Stroke · doi:10.1161/01.str.27.12.2230 · Cited by 159
Kuusi, T., Nieminen, M. S., Ehnholm, C., Yki‐Järvinen, H., Valle, M., Nikkilä, E. A., & Taskinen, M. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.2.237 · Cited by 159
Lack of an association between apolipoprotein E ϵ4 and Alzheimer's disease in elderly nigerians
Osuntokun, B. O., Sahota, A. S., Ogunniyi, A. O., Gureje, O., Baiyewu, O., Adeyinka, A. O., Oluwole, S., Komolafe, O. O., Hall, K. S., Unverzagt, F. W., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380319 · Cited by 158
Ohm, T. G., Kirca, M., Bohl, J., Scharnagl, H., Groβ, W., & März, W. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00596-w · Cited by 157
Brewer, H. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00308-2 · Cited by 158
Ferrières, J., Lambert, J., Lussier‐Cacan, S., & Davignon, J. (1995) · Circulation · doi:10.1161/01.cir.92.3.290 · Cited by 155
Self-citationHachinski, V. C. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040031011 · Cited by 153
Molecular basis of exchangeable apolipoprotein function
Narayanaswami, V., & Ryan, R. O. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00176-6 · Cited by 152
Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections
Hamilton, R., Wong, J., Guo, L., Krisans, S., & Havel, R. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42343-0 · Cited by 129
López‐Miranda, J., Ordovás, J. M., Mata, P., Lichtenstein, A. H., Clevidence, B., Judd, J. T., & Schaefer, E. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39943-0 · Cited by 151
The role of apolipoprotein E genetic variants in lipoprotein disorders.
RALL, S. C., & MAHLEY, R. W. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb01254.x · Cited by 150
Watts, G. F., Mandalia, S., Brunt, J. N. H., Slavin, B. M., COLTART, D. J., & Lewis, B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90199-x · Cited by 146
Stress and lipoprotein metabolism: Modulators and mechanisms
Brindley, D. N., McCann, B. S., NIAURA, R. S., Stoney, C. M., & Suarez, E. C. (1993) · Metabolism · doi:10.1016/0026-0495(93)90255-m · Cited by 147
Demant, T., Bedford, D., Packard, C. J., & Shepherd, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115459 · Cited by 145
Zareparsi, S. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1253 · Cited by 145
RPGR mutation associated with retinitis pigmentosa, impaired hearing, and sinorespiratory infections
Zito, I., Downes, S. M., Patel, R. J., Cheetham, M. E., Ebenezer, N. D., Jenkins, S. A., Bhattacharya, S. S., Webster, A. R., Holder, G. E., Bird, A. C., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.609 · Cited by 145
Sequence Diversity in 36 Candidate Genes for Cardiovascular Disorders
Cambien, F., Poirier, O., Nicaud, V., Herrmann, S.-M., Mallet, C., Ricard, S., Behague, I., Hallet, V., Blanc, H., Loukaci, V., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302448 · Cited by 144
Eggertsen, G., Tegelman, R., Ericsson, S., Angelin, B., & Berglund, L. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.10.2125 · Cited by 143
Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E 4 Allele
Reed, T., Carmelli, D., Swan, G. E., Breitner, J. C. S., Welsh-Bohmer, K. A., Jarvik, G. P., Deeb, S., & Auwerx, J. H. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540240033012 · Cited by 143
Skoog, I. G., Hesse, C., Aevarsson, Ó., Landahl, S., Wahlström, J., Fredman, P., & Blennow, K. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.1.37 · Cited by 143
Shimano, H., Yamada, N., Katsuki, M., Shimada, M., Gotoda, T., Harada, K., Murase, T., Fukazawa, C., Takaku, F., & Yazaki, Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1750 · Cited by 143
Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians
Kervinen, K., Savolainen, M. J., Salokannel, J., Hynninen, A., Heikkinen, J., Ehnholm, C., Koistinen, M. J., & Kesäniemi, Y. A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90011-6 · Cited by 142
Yu, K. H., Rustgi, A. K., & Blair, I. A. (2005) · Journal of Proteome Research · doi:10.1021/pr050174l · Cited by 141
Jousilahti, P., Puska, P., Vartiainen, E., Pekkanen, J., & Tuomilehto, J. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00581-1 · Cited by 141
Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
Hendrie, H. C., Hall, K. S., Hui, S. L., Unverzagt, F. W., Yu, C., Lahiri, D. K., Sahota, A. S., Farlow, M. R., Musick, B. S., Brashear, A., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410370123 · Cited by 141
Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis.
Houlston, R. S. (1999) · PubMed · Cited by 140
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139
Kessler, C., Spitzer, C., Stauske, D., Mende, S., Stadlmüller, J., Walther, R., & Rettig, R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2880 · Cited by 139
Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors
Remaley, A. T., Rifai, N., & Warnick, G. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00027-5 · Cited by 139
Xhignesse, M., Lussier‐Cacan, S., Sing, C. F., Kessling, A. M., & Davignon, J. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.1100 · Cited by 139
Self-citationInfectivity of Hepatitis C Virus Is Influenced by Association with Apolipoprotein E Isoforms
Hishiki, T., Shimizu, Y., Tobita, R., Sugiyama, K., Ogawa, K., Funami, K., Ohsaki, Y., Fujimoto, T., Takaku, H., Wakita, T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01063-10 · Cited by 138
Aleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138
Lipoprotein metabolism and its relationship to atherosclerosis
Ginsberg, H. N. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30174-2 · Cited by 137
An Update on Postoperative Cognitive Dysfunction
Tsai, T. L., Sands, L. P., & Leung, J. M. (2010) · Advances in Anesthesia · doi:10.1016/j.aan.2010.09.003 · Cited by 136
Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels
Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012302.11991.42 · Cited by 136
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
de Knijff, P., van den Maagdenberg, A. M. J. M., Frants, R. R., & Havekes, L. M. (1994) · Human Mutation · doi:10.1002/humu.1380040303 · Cited by 137
Hirashiki, A., Yamada, Y., Murase, Y., Suzuki, Y., Kataoka, H., Morimoto, Y., Tajika, T., Murohara, T., & Yokota, M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01062-3 · Cited by 135
Midlife Vascular Risk Factors and Alzheimer's Disease: Evidence from Epidemiological Studies
Tolppanen, A., Solomon, A., Soininen, H. S., & Kivipelto, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120802 · Cited by 143
TANG, M., Maestre, G. E., TSAI, W., Liu, X., FENG, L., Chung, W., Chun, M. R., Schofield, P. W., Stern, Y., Tycko, B., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32593.x · Cited by 135
Zhang, S., Picard, M. H., Vasile, E., Zhu, Y. Y., Raffaı̈, R. L., Weisgraber, K. H., & Krieger, M. (2005) · Circulation · doi:10.1161/circulationaha.104.523563 · Cited by 134
The genetics of human longevity: an intricacy of genes, environment, culture and microbiome
Dato, S., Rose, G., Crocco, P., Monti, D., Garagnani, P., Franceschi, C., & Passarino, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.011 · Cited by 135
Zechner, R., Moser, R., Newman, T. C., Fried, S. K., & Breslow, J. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99263-x · Cited by 134
Apolipoprotein E Recycling: Implications for Dyslipidemia and Atherosclerosis
Heeren, J., Beisiegel, U., & Grewal, T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201282.64751.47 · Cited by 123
Volcik, K. A., Barkley, R. A., Hutchinson, R. G., Mosley, T. H., HEISS, G. M., Sharrett, A. R., Ballantyne, C. M., & Boerwinkle, E. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj202 · Cited by 135
Subclinical Vitamin K Deficiency in Hemodialysis Patients
Pilkey, R. M., Morton, A. R., Boffa, M. B., Noordhof, C., Day, A. G., Su, Y., Miller, L., Koschinsky, M. L., & Booth, S. L. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.041 · Cited by 132
Duara, R., Barker, W., Lopez-Alberola, R., Loewenstein, D., Grau, L. B., Gilchrist, D. M., Sevush, S., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.6.1575 · Cited by 134
Joint Effect of the APOE Gene and Midlife Systolic Blood Pressure on Late-Life Cognitive Impairment
Peila, R., White, L. R., Petrovitch, H., Masaki, K., Ross, G. W., Havlik, R. J., & Launer, L. J. (2001) · Stroke · doi:10.1161/hs1201.100392 · Cited by 131
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
